{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:32:46Z","timestamp":1783780366567,"version":"3.55.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.eimc.2015.05.005","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T10:02:20Z","timestamp":1434708140000},"page":"411-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vacunas frente al virus de la varicela z\u00f3ster"],"prefix":"10.1016","volume":"33","author":[{"given":"Luis","family":"Salleras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Salleras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Soldevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2015.05.005_bib0005","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM198312083092306","article-title":"Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so-benign virus","volume":"309","author":"Weller","year":"1983","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2015.05.005_bib0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Hespes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2015.05.005_bib0015","series-title":"Vacunaciones preventivas","first-page":"311","article-title":"Vacuna antivaricela-zoster","author":"Salleras","year":"2003"},{"issue":"Supl. 4","key":"10.1016\/j.eimc.2015.05.005_bib0020","first-page":"29","article-title":"Vacunas frente al virus de la varicela zoster","volume":"25","author":"Salleras","year":"2007","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.eimc.2015.05.005_bib0025","series-title":"Vaccines","first-page":"837","article-title":"Varicella vaccine","author":"Gershon","year":"2013"},{"key":"10.1016\/j.eimc.2015.05.005_bib0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1586\/14760584.5.4.431","article-title":"Prevention of shingles by varicella zoster virus vaccination","volume":"5","author":"Holodniy","year":"2006","journal-title":"Expert Rev Vaccines."},{"key":"10.1016\/j.eimc.2015.05.005_bib0035","series-title":"Vaccines","first-page":"969","article-title":"Zoster vaccine","author":"Levin","year":"2013"},{"key":"10.1016\/j.eimc.2015.05.005_bib0040","series-title":"Herpes zoster and postherpetic neuralgia","first-page":"39","article-title":"Epidemiology and natural history of herpes zoster and postherpetic neuralgia","author":"Dworkin","year":"2001"},{"key":"10.1016\/j.eimc.2015.05.005_bib0045","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.jaad.2007.08.046","article-title":"Herpes zoster: Epidemiology, natural history and common complications","volume":"57","author":"Weinberg","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.eimc.2015.05.005_bib0050","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1056\/NEJMp058091","article-title":"Aging, immunity and the varicella-zoster virus","volume":"352","author":"Arvin","year":"2005","journal-title":"N Engl J Med."},{"issue":"Suppl. 1","key":"10.1016\/j.eimc.2015.05.005_bib0055","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpain.2007.10.002","article-title":"Natural history and treatment of herpes zoster","volume":"9","author":"Schmader","year":"2008","journal-title":"J Pain."},{"key":"10.1016\/j.eimc.2015.05.005_bib0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1576-9887(09)73478-8","article-title":"Historia natural de la infecci\u00f3n por el virus de la varicela zoster","volume":"10","author":"Salleras","year":"2009","journal-title":"Vacunas."},{"issue":"Suppl. 2","key":"10.1016\/j.eimc.2015.05.005_bib0065","first-page":"S54","article-title":"Humoral and cellular immunity to varicella-zoster virus: an overview","volume":"197","author":"Arvin","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0070","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1128\/JVI.79.5.2651-2658.2005","article-title":"Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model","volume":"79","author":"Ku","year":"2005","journal-title":"J Virol."},{"issue":"Suppl 1","key":"10.1016\/j.eimc.2015.05.005_bib0075","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1386-6532(10)70002-0","article-title":"Advances in the understanding of the pathogenesis and epidemiology of herpes zoster","volume":"48","author":"Gershon","year":"2010","journal-title":"J Clin Virol."},{"key":"10.1016\/j.eimc.2015.05.005_bib0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/CMR.00052-13","article-title":"Pathogenesis and current approaches to control of varicella-zoster virus infections","volume":"26","author":"Gershon","year":"2013","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.eimc.2015.05.005_bib0085","first-page":"17","article-title":"Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children","volume":"123","author":"Gershon","year":"2012","journal-title":"Trans Am Clin Climatol Assoc."},{"key":"10.1016\/j.eimc.2015.05.005_bib0090","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s13365-011-0070-1","article-title":"Varicella zoster virus (VZV) infects and establishes latency in enteric neurons","volume":"17","author":"Chen","year":"2011","journal-title":"J Neurovirol."},{"key":"10.1016\/j.eimc.2015.05.005_bib0095","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.coi.2012.06.002","article-title":"Immune senescence and vaccines to prevent herpes zoster in older persons","volume":"24","author":"Levin","year":"2012","journal-title":"Curr Opin Immunol."},{"key":"10.1016\/j.eimc.2015.05.005_bib0100","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.05.005_bib0105","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1212\/WNL.30.6.582","article-title":"Selective decline in cellular immune response to varicella-zoster in the elderly","volume":"30","author":"Miller","year":"1980","journal-title":"Neurology."},{"key":"10.1016\/j.eimc.2015.05.005_bib0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/IAI.32.1.24-27.1981","article-title":"Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged","volume":"32","author":"Berger","year":"1981","journal-title":"Infect Immun."},{"key":"10.1016\/j.eimc.2015.05.005_bib0115","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2014.01.019","article-title":"Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study","volume":"32","author":"Chlibek","year":"2014","journal-title":"Vaccine."},{"issue":"Suppl 8","key":"10.1016\/j.eimc.2015.05.005_bib0120","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1212\/WNL.45.12_Suppl_8.S41","article-title":"Immunization to reduce the frequency and severity of herpes zoster and its complications","volume":"45","author":"Oxman","year":"1995","journal-title":"Neurology."},{"key":"10.1016\/j.eimc.2015.05.005_bib0125","first-page":"151","article-title":"Use of varicella vaccines to prevent herpes zoster in older individuals","volume":"17","author":"Levin","year":"2001","journal-title":"Arch Virol Suppl."},{"key":"10.1016\/j.eimc.2015.05.005_bib0130","first-page":"657","article-title":"Prevention of herpes zoster","volume":"10","author":"Levin","year":"1996"},{"key":"10.1016\/j.eimc.2015.05.005_bib0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/infdis\/166.2.253","article-title":"Immune response of elderly individuals to a live attenuated varicella vaccine","volume":"166","author":"Levin","year":"1992","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0140","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis."},{"issue":"Suppl 1","key":"10.1016\/j.eimc.2015.05.005_bib0145","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1086\/514264","article-title":"Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect","volume":"178","author":"Levin","year":"1998","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0150","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2015.05.005_bib0155","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0160","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/infdis\/jit365","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age","volume":"208","author":"Chlibek","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2015.05.005_bib0165","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2015.05.005_bib0170","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1056\/NEJMe1505050","article-title":"A new vaccine to prevent herpes zoster","volume":"372","author":"Cohen","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2015.05.005_bib0175","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1576-9887(05)73012-0","article-title":"Varicela en el adolescente y adulto: carga de la enfermedad y estrategias de prevenci\u00f3n mediante la vacunaci\u00f3n","volume":"3","author":"Salleras","year":"2005","journal-title":"Vacunas."},{"key":"10.1016\/j.eimc.2015.05.005_bib0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1128\/CMR.18.1.70-80.2005","article-title":"Preventing varicella-zoster disease","volume":"18","author":"Hambleton","year":"2005","journal-title":"Clinical Microbiology Reviews."},{"key":"10.1016\/j.eimc.2015.05.005_bib0185","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1590\/S1135-57272009000500012","article-title":"Epidemiolog\u00eda de la varicela en los per\u00edodos pre y postvacunaci\u00f3n","volume":"83","author":"Pe\u00f1a-Rey","year":"2009","journal-title":"Rev Esp Salud P\u00fablica."},{"key":"10.1016\/j.eimc.2015.05.005_bib0190","first-page":"71","article-title":"Incidencia de la varicela y el herpes zoster antes de la introducci\u00f3n de la vacunaci\u00f3n sistem\u00e1tica infantil en Navarra, 2005-2006","volume":"30","author":"Garc\u00eda Cenoz","year":"2007","journal-title":"An Sist Sanit Navarr."},{"key":"10.1016\/j.eimc.2015.05.005_bib0195","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/infdis\/156.5.851","article-title":"Seroepidemiology of varicella in children from Spain","volume":"156","author":"Cilla","year":"1987","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0264-410X(00)00178-X","article-title":"Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes","volume":"19","author":"Salleras","year":"2001","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.05.005_bib0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00430-007-0064-z","article-title":"Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain)","volume":"1997","author":"Salleras","year":"2008","journal-title":"Med Micriobiol Immunol."},{"key":"10.1016\/j.eimc.2015.05.005_bib0210","series-title":"I encuesta de seroprevalencia de la Comunidad Aut\u00f3noma del Pa\u00eds Vasco","author":"Arteagoitia","year":"2011"},{"key":"10.1016\/j.eimc.2015.05.005_bib0215","first-page":"93","volume":"10","author":"Gershon","year":"1995"},{"key":"10.1016\/j.eimc.2015.05.005_bib0220","first-page":"791","article-title":"Recommendations for the use of live attenuated varicella vaccine","volume":"95","year":"1995","journal-title":"Pediatrics."},{"issue":"RR11","key":"10.1016\/j.eimc.2015.05.005_bib0225","first-page":"1","article-title":"Prevention of varicella. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"45","year":"1996","journal-title":"MMWR."},{"key":"10.1016\/j.eimc.2015.05.005_bib0230","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0891-5520(05)70313-5","article-title":"The epidemiology of varicella-zoster virus infection","volume":"10","author":"Wharton","year":"1996","journal-title":"Infect Dis Clin. North America."},{"key":"10.1016\/j.eimc.2015.05.005_bib0235","series-title":"Varicella-zoster virus","first-page":"206","article-title":"Clinical manifestations of varicella","author":"La Russa","year":"2000"},{"issue":"Suppl 2","key":"10.1016\/j.eimc.2015.05.005_bib0240","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1086\/522155","article-title":"Varicella among adults: data from an active surveillance project, 1995-2005","volume":"197","author":"Marin","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0245","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1086\/425613","article-title":"High rate of varicella complications among mexican-born adults Alabama","volume":"39","author":"Danovaro-Holliday","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0250","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1086\/425618","article-title":"Varicella vaccine for susceptible adults: do it today","volume":"39","author":"Gershon","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0255","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/502445","article-title":"Screening healthcare workers for varicella-zoster virus: can we trust the history?","volume":"25","author":"Almuneef","year":"2004","journal-title":"Infect Control Hosp Epidemiol."},{"key":"10.1016\/j.eimc.2015.05.005_bib0260","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1542\/peds.56.3.388","article-title":"Varicella in children with cancer: 77 cases","volume":"80","author":"Feldman","year":"1975","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0265","first-page":"425","article-title":"Varicella in the normal and immunocompromissed host","volume":"3","author":"Watson","year":"1996","journal-title":"Bailliere's Clinical Infectious Diseases."},{"key":"10.1016\/j.eimc.2015.05.005_bib0270","series-title":"Varicella-zoster virus.","first-page":"206","article-title":"Varicella and herpes zoster in pregnancy and the newborn","author":"Enders","year":"2000"},{"issue":"Suppl 2","key":"10.1016\/j.eimc.2015.05.005_bib0275","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/522146","article-title":"Epidemiology of varicella hospitalizations in the United States, 1995-2005","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0280","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1542\/peds.2004-0012","article-title":"Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States","volume":"114","author":"Davis","year":"2004","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0285","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00006454-200107000-00002","article-title":"Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: a baseline assessment of the shifting epidemiology of varicella disease","volume":"20","author":"Coplan","year":"2001","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0290","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1542\/peds.2010-0962","article-title":"Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era","volume":"127","author":"Lopez","year":"2011","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0295","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1023\/B:EJEP.0000036791.43264.84","article-title":"The burden of severe varicella in Spain, 1995--2000 period","volume":"19","author":"Gil","year":"2004","journal-title":"Eur J Epidemiol."},{"key":"10.1016\/j.eimc.2015.05.005_bib0300","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2004.04.004","article-title":"Epidemiology of severe varicella-zoster virus infection in Spain","volume":"22","author":"Gil","year":"2004","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.05.005_bib0305","series-title":"Varicella-zoster virus","first-page":"206","article-title":"Epidemiology of varicella","author":"Seward","year":"2000"},{"key":"10.1016\/j.eimc.2015.05.005_bib0310","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2015.05.005_bib0315","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0891-5520(05)70309-3","article-title":"Vaccine development","volume":"10","author":"Takahashi","year":"1996","journal-title":"Infect Dis Clin North Am."},{"issue":"suppl 3","key":"10.1016\/j.eimc.2015.05.005_bib0320","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1093\/infdis\/174.Supplement_3.S310","article-title":"Varicella vaccine: The japanese experience","volume":"174","author":"Asano","year":"1996","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0325","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jmv.1890320310","article-title":"Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glicoprotein antigen","volume":"32","author":"Wasmuth","year":"1990","journal-title":"J Med Virol"},{"issue":"Suppl 11","key":"10.1016\/j.eimc.2015.05.005_bib0330","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1093\/clind\/13.Supplement_11.S957","article-title":"Human immune responses to live attenuated varicella vaccine","volume":"13","author":"Gershon","year":"1991","journal-title":"Rev Infect Dis."},{"issue":"Suppl 4","key":"10.1016\/j.eimc.2015.05.005_bib0335","first-page":"53","article-title":"Production and quality control of the OKA strain live varicella vaccine","volume":"61","author":"D\u2019Hont","year":"1985","journal-title":"Postgrad Med J."},{"issue":"Suppl 3","key":"10.1016\/j.eimc.2015.05.005_bib0340","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1093\/infdis\/174.Supplement_3.S324","article-title":"Immunogenicity and safety of a live attenuated varicella vaccine (OKA\/SB Bio) in healthy children","volume":"174","author":"Meurice","year":"1996","journal-title":"J Infect Dis."},{"issue":"Suppl 4","key":"10.1016\/j.eimc.2015.05.005_bib0345","first-page":"129","article-title":"Live varicella vaccine in healthy individuals","volume":"61","author":"Just","year":"1985","journal-title":"Postgrad Med J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0350","first-page":"89","article-title":"Summary of clinical studies with the OKA live varicella vaccine produced by Smith Kline-RIT","volume":"27","author":"Andr\u00e9","year":"1984","journal-title":"Biken Journal."},{"key":"10.1016\/j.eimc.2015.05.005_bib0355","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/BF01957158","article-title":"Use of reformulated OKA Strain varicella vaccine (SKB\/OKA) in healthy children","volume":"155","author":"Tan","year":"1996","journal-title":"Eur J Pediatr."},{"key":"10.1016\/j.eimc.2015.05.005_bib0360","first-page":"1295","article-title":"Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months","volume":"85","author":"Ramkisoon","year":"1995","journal-title":"S Afr Med J"},{"issue":"Suppl","key":"10.1016\/j.eimc.2015.05.005_bib0365","first-page":"748","article-title":"Varicella vaccine studies in healthy children and adults","volume":"78","author":"Arbeter","year":"1986","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0370","first-page":"604","article-title":"Varicella vaccine (Varivax) in healthy children and adolescents. Results froma clinical trails, 1987 to 1989","volume":"87","author":"White","year":"1991","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0375","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/clinids\/20.2.316","article-title":"Humoral and cell mediate immune responses in healthy children after one or two doses of varicella vaccine","volume":"20","author":"Watson","year":"1995","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0380","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/0264-410X(95)00135-N","article-title":"Varicella vaccine","volume":"13","author":"Ellis","year":"1995","journal-title":"Vaccine."},{"issue":"Suppl","key":"10.1016\/j.eimc.2015.05.005_bib0385","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/infdis\/166.Supplement_1.S63","article-title":"Varicella vaccine: the American experience","volume":"166","author":"Gershon","year":"1992","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0390","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/infdis\/165.5.852","article-title":"Immunization of healthy adults with live attenuated varicella vaccine","volume":"165","author":"Ndumbe","year":"1992","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0395","first-page":"143","article-title":"Protective effect of vaccination against chickenpox","volume":"49","author":"Tlesnik","year":"2000","journal-title":"Epidemiol Mikrobiol Imunol."},{"key":"10.1016\/j.eimc.2015.05.005_bib0400","first-page":"259","article-title":"Reactogenicity and immunogenicity of a varicella vaccine in Healthy seronegative and seropositive subjects","volume":"33","author":"Barzaga","year":"2002","journal-title":"South East Asian J Trop Med Public Health."},{"key":"10.1016\/j.eimc.2015.05.005_bib0405","first-page":"697","article-title":"Advantage of a two-dose versus one dose varicella vaccine in healthy non-immune teeangers and young adults","volume":"35","author":"Kusowon","year":"2004","journal-title":"Southeast Asian J Trop Med Public Health."},{"key":"10.1016\/j.eimc.2015.05.005_bib0410","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0891-5520(05)70316-0","article-title":"Clinical trials of varicella vaccine in healthy adolescents and adults","volume":"10","author":"Arberter","year":"1996","journal-title":"Infect Dis Clin North America."},{"key":"10.1016\/j.eimc.2015.05.005_bib0415","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/infdis\/158.1.132","article-title":"Immunization of healthy adults with live attenuatd varicella vaccine","volume":"158","author":"Gershon","year":"1988","journal-title":"J Infect Dis."},{"issue":"RR-4","key":"10.1016\/j.eimc.2015.05.005_bib0420","first-page":"1","article-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP). Prevention of Varicella","volume":"56","year":"2007","journal-title":"MMWR."},{"issue":"RR-3","key":"10.1016\/j.eimc.2015.05.005_bib0425","first-page":"1","article-title":"Recommendations of the Advisory Committee on Immunization Practices (ACIP). Use of combination measles, mumps, rubella and varicela vaccine","volume":"59","year":"2010","journal-title":"MMWR."},{"key":"10.1016\/j.eimc.2015.05.005_bib0430","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicela vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0435","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0440","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/peds.2005-0092","article-title":"A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax","volume":"117","author":"Reisinger","year":"2006","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0445","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0264-410X(95)00046-4","article-title":"Safety, tolerability, and immunogenicity of two regimens of Oka\/Merck varicella vaccine (Varivax) in healthy adolescents and adults","volume":"13","author":"Kuter","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.eimc.2015.05.005_bib0450","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","article-title":"Live attenuated varicella vaccine: efficacy trial in healthy children","volume":"310","author":"Weibel","year":"1984","journal-title":"N Engl J Med."},{"issue":"Suppl 3","key":"10.1016\/j.eimc.2015.05.005_bib0455","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1093\/infdis\/174.Supplement_3.S330","article-title":"Efficacy of high-titer attenuated varicella vaccine in healthy young children","volume":"174","author":"Varis","year":"1996","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0460","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0264-410X(91)90189-D","article-title":"Oka\/Merk varicella vaccine in healthy children: final report of a 2-year efficacy stydy and 7-year follow up studies","volume":"9","author":"Kuter","year":"1991","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.05.005_bib0465","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.1985.03360170075034","article-title":"Live Oka\/Merck varicella vaccine in healthy children: further clinical and laboratory assessment","volume":"254","author":"Weibel","year":"1985","journal-title":"JAMA."},{"key":"10.1016\/j.eimc.2015.05.005_bib0470","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0891-5520(05)70315-9","article-title":"Clinical trials of varicella vaccine in healthy children","volume":"10","author":"White","year":"1996","journal-title":"Infect Dis Clin North America."},{"issue":"Suppl 2","key":"10.1016\/j.eimc.2015.05.005_bib0475","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US program: a review","volume":"197","author":"Seward","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0480","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.1997.03550180045035","article-title":"Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center","volume":"278","author":"Izurieta","year":"1997","journal-title":"JAMA."},{"key":"10.1016\/j.eimc.2015.05.005_bib0485","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00006454-199912000-00004","article-title":"Postlicensure study of varicella vaccine effectiveness in a day care setting","volume":"18","author":"Clements","year":"1999","journal-title":"Pediatric Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0490","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.105.1.84","article-title":"Postexposure effectiveness of varicella vaccine","volume":"105","author":"Watson","year":"2000","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0495","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1056\/NEJM200103293441302","article-title":"The effectiveness of the varicella vaccine in clinical practice","volume":"344","author":"Vazquez","year":"2001","journal-title":"N Egl J Med."},{"key":"10.1016\/j.eimc.2015.05.005_bib0500","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/341089","article-title":"Yonger age at vaccination may increase risk of varicella vaccine failure","volume":"186","author":"Galil","year":"2002","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0505","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1542\/peds.113.3.455","article-title":"Chickenpox outbreak in a highly vaccinated school population","volume":"113","author":"Tugwell","year":"2004","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0510","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/jama.1997.03550180079042","article-title":"Vaccination for varicella. Just do it!","volume":"278","author":"Shapiro","year":"1997","journal-title":"JAMA."},{"key":"10.1016\/j.eimc.2015.05.005_bib0515","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after the introduction of varicella vaccine in the United States 1995-2000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA."},{"key":"10.1016\/j.eimc.2015.05.005_bib0520","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.inf.0000114906.78716.64","article-title":"Use of a computerized database to study the effectiveness of an attenuated varicella vaccine","volume":"23","author":"Passwell","year":"2004","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0525","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.inf.0000160947.89942.30","article-title":"Effectiveness of the Oka\/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel","volume":"24","author":"Sheffer","year":"2005","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0530","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00006454-199803000-00020","article-title":"Post-exposure varicella vaccination in siblings of children with active varicella","volume":"17","author":"Salzman","year":"1998","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0535","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/INF.0b013e3181b36022","article-title":"Effectiveness of varicella vaccines as postexposure prophylaxis","volume":"29","author":"Brotons","year":"2010","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0540","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0545","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2009.10.086","article-title":"Comparative varicella vaccine effectiveness during outbreaks in day-care centres","volume":"28","author":"Spackova","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.05.005_bib0550","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/INF.0b013e3181d9f657","article-title":"Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006","volume":"29","author":"Nguyen","year":"2010","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0555","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.vaccine.2003.10.021","article-title":"Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella","volume":"22","author":"Mullooly","year":"2004","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.05.005_bib0560","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00006454-200106000-00014","article-title":"Update on varicella","volume":"20","author":"Seward","year":"2001","journal-title":"Ped Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0565","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.inf.0000140786.15816.38","article-title":"Varicella infections and varicella vaccine in the 21st century","volume":"23","author":"Vazquez","year":"2004","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0570","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0575","first-page":"884","article-title":"Decline in annual incidence of varicella--selected states, 1990-2001","volume":"52","year":"2003","journal-title":"MMWR."},{"key":"10.1016\/j.eimc.2015.05.005_bib0580","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics."},{"key":"10.1016\/j.eimc.2015.05.005_bib0585","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1467-842X.1998.tb01405.x","article-title":"Varicella-zoster virus infection in Australia","volume":"22","author":"Chant","year":"1998","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.eimc.2015.05.005_bib0590","first-page":"213","article-title":"Fatal varicella infectionS in Singapore","volume":"34","author":"Lam","year":"1993","journal-title":"Singapore Med J."},{"key":"10.1016\/j.eimc.2015.05.005_bib0595","first-page":"282","article-title":"Epidemiology of chickenpox in Scotland: 1981 to 1998","volume":"3","author":"Bramley","year":"2000","journal-title":"Commun Dis Public Health."},{"key":"10.1016\/j.eimc.2015.05.005_bib0600","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S0950268802007720","article-title":"Varicella in non-immune persons: incidence, hospitalization and mortality rates","volume":"129","author":"Boelle","year":"2002","journal-title":"Epidemiol Infect."},{"issue":"Suppl 3","key":"10.1016\/j.eimc.2015.05.005_bib0605","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.1093\/infdis\/174.Supplement_3.S314","article-title":"Varicella-zoster virus epidemiology \u2013 a changing scene?","volume":"174","author":"Fairley","year":"1996","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0610","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.323.7321.1091","article-title":"Deaths form chickenpox in England and Wales 1995-7: analysis of routine mortality data","volume":"323","author":"Rawson","year":"2001","journal-title":"BMJ."},{"key":"10.1016\/j.eimc.2015.05.005_bib0615","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/003335490712200204","article-title":"Varicella exposure and herpes zoster disease incidence in older adults in the U.S","volume":"122","author":"Chaves","year":"2007","journal-title":"Public Health Reports."},{"key":"10.1016\/j.eimc.2015.05.005_bib0620","doi-asserted-by":"crossref","first-page":"609","DOI":"10.7326\/0003-4819-152-9-201005040-00011","article-title":"Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination","volume":"152","author":"Donahue","year":"2010","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.eimc.2015.05.005_bib0625","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1346-8138.2010.00804.x","article-title":"Do the health-care workers gain protection against herpes zoster infection?. A 6-year population-based study in Taiwan","volume":"27","author":"Wu","year":"2010","journal-title":"J Dermat."},{"key":"10.1016\/j.eimc.2015.05.005_bib0630","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/651078","article-title":"Increasing incidence of herpes zoster among Veterans","volume":"50","author":"Rimland","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0635","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.vaccine.2010.01.036","article-title":"A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia","volume":"28","author":"Carville","year":"2010","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.05.005_bib0640","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clin Infect Dis."},{"issue":"supl. 1","key":"10.1016\/j.eimc.2015.05.005_bib0645","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1576-9887(14)70070-6","article-title":"Vacunaci\u00f3n antivaricela para adolescentes y adultos","volume":"15","author":"Salleras","year":"2014","journal-title":"Vacunas."},{"key":"10.1016\/j.eimc.2015.05.005_bib0650","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1542\/pir.29-1-5","article-title":"Varicella-zoster virus infections","volume":"29","author":"Gershon","year":"2008","journal-title":"Pediatr Rev."},{"key":"10.1016\/j.eimc.2015.05.005_bib0655","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1016\/j.vaccine.2011.08.023","article-title":"Contacts with children and young people and adult risk of suffering herpes zoster","volume":"29","author":"Salleras","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.05.005_bib0660","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2015.05.005_bib0665","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.eimc.2015.05.005_bib0670","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1471-0528.2007.01454.x","article-title":"Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age","volume":"114","author":"Plans","year":"2007","journal-title":"BJOG."},{"key":"10.1016\/j.eimc.2015.05.005_bib0675","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4161\/hv.1.5.2216","article-title":"Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent's reported history and the medical file for identification of potential candidates for vaccination","volume":"1","author":"D\u00edez-Domingo","year":"2005","journal-title":"Human Vaccines."},{"key":"10.1016\/j.eimc.2015.05.005_bib0680","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2015.05.005_bib0685","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2296-11-33","article-title":"Community\u2019 HZRGotV. Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain)","volume":"11","author":"Cebri\u00e1n-Cuenca","year":"2010","journal-title":"BMC Farm Pract"},{"issue":"supl. 1","key":"10.1016\/j.eimc.2015.05.005_bib0690","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1576-9887(14)70075-5","article-title":"Vacunaci\u00f3n frente al herpes zoster","author":"Salleras","year":"2014","journal-title":"Vacunas."},{"key":"10.1016\/j.eimc.2015.05.005_bib0695","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4161\/hv.34421","article-title":"Herpes zoster and postherpetic neuralgia in Catalonia (Spain)","volume":"11","author":"Salleras","year":"2015","journal-title":"Hum Vaccin Immunother."},{"issue":"RR\u20135","key":"10.1016\/j.eimc.2015.05.005_bib0700","first-page":"21","article-title":"Prevention of Herpes Zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","year":"2008","journal-title":"MMWR."},{"key":"10.1016\/j.eimc.2015.05.005_bib0705","unstructured":"European Medicines Agency: Zostavax. Disponible en: www.emea.eu\/humandocs\/PDFs\/EPAR\/zostavax\/067406en6.pdf."},{"key":"10.1016\/j.eimc.2015.05.005_bib0710","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and Immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized. Placebo-Controlled Study","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0715","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0720","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","article-title":"Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy","volume":"55","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0725","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0730","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/cid\/ciu922","article-title":"Editorial commentary: Waning efficacy of the herpes zoster vaccine","volume":"60","author":"Whitley","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.05.005_bib0735","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood-2014-04-573048","article-title":"A phase 1\/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients","volume":"124","author":"Stadtmauer","year":"2014","journal-title":"Blood."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15001925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15001925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T06:23:17Z","timestamp":1652509397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X15001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":147,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0213005X15001925"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2015.05.005","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vacunas frente al virus de la varicela z\u00f3ster","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2015.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}